(1)
Soung, J.; King, B.; Tziotzios, C.; Rudnicka, L.; Joly, P.; Gooderham, M.; Sinclair, R.; Wajsbrot, D.; Tran, H.; Wolk, R. Integrated Safety Analysis of Ritlecitinib in Adolescent Patients With Alopecia Areata from the Randomized, Placebo-Controlled ALLEGRO Phase 2b/3 and Ongoing Open-Label Phase 3 ALLEGRO-LT Studies. J of Skin 2023, 7, s294.